- Home
- BNTC vs GILT Comparison
BNTC vs GILT Comparison
Compare BNTC & GILT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- GILT
- Stock Information
- Founded
- BNTC 1995
- GILT 1987
- Country
- BNTC United States
- GILT Israel
- Employees
- BNTC N/A
- GILT N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- GILT Radio And Television Broadcasting And Communications Equipment
- Sector
- BNTC Health Care
- GILT Technology
- Exchange
- BNTC Nasdaq
- GILT Nasdaq
- Market Cap
- BNTC 352.5M
- GILT 400.3M
- IPO Year
- BNTC N/A
- GILT 1993
- Fundamental
- Price
- BNTC $13.63
- GILT $6.52
- Analyst Decision
- BNTC Strong Buy
- GILT Strong Buy
- Analyst Count
- BNTC 7
- GILT 2
- Target Price
- BNTC $24.71
- GILT $8.50
- AVG Volume (30 Days)
- BNTC 34.2K
- GILT 178.0K
- Earning Date
- BNTC 05-16-2025
- GILT 05-19-2025
- Dividend Yield
- BNTC N/A
- GILT N/A
- EPS Growth
- BNTC N/A
- GILT 6.30
- EPS
- BNTC N/A
- GILT 0.44
- Revenue
- BNTC N/A
- GILT $305,448,000.00
- Revenue This Year
- BNTC N/A
- GILT $45.29
- Revenue Next Year
- BNTC N/A
- GILT $11.74
- P/E Ratio
- BNTC N/A
- GILT $14.96
- Revenue Growth
- BNTC N/A
- GILT 14.79
- 52 Week Low
- BNTC $5.74
- GILT $4.04
- 52 Week High
- BNTC $16.90
- GILT $8.05
- Technical
- Relative Strength Index (RSI)
- BNTC 49.98
- GILT 55.25
- Support Level
- BNTC $13.35
- GILT $6.29
- Resistance Level
- BNTC $15.69
- GILT $6.73
- Average True Range (ATR)
- BNTC 0.74
- GILT 0.17
- MACD
- BNTC -0.03
- GILT 0.05
- Stochastic Oscillator
- BNTC 20.46
- GILT 66.67
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About GILT Gilat Satellite Networks Ltd.
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs) and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.